Mrs Klaudia Haczkiewicz Germany

LTS Lohmann Therapie-Systeme AG
Head of Business Development 

Dr Thomas Högn Germany

Natrapharm

NATRAPHARM,  Philippines www.natrapharm.com

Core objective: To market pharmaceutical products through licensing and/or supply agreement with reputable international companies.

Organization: The total headcount is 600, among which 518 are field personnel and 82 in head office (top executives, marketing, registration, finance and HR).

NATRAPHARM Inc. is mainly focussing on antiinfectives, antibiotics, anti-asthma, anti-allergy, pediatricians. The management, the distribution and the services are common to both companies, Natrapharm Inc. and Patriot Pharmaceutical corporation. PATRIOT PHARMACEUTICAL CORPORATION handles cardiology and metabolic, neurology, psychiatry, surgery, pain management, and nephrology.

Sales performance: Natrapharm Group has one of the highest growth rate of the ethical market.

Natrapharm Group is ranking between the 10 leading pharmaceutical companies with more than 70 million US$ (combined drugstore and hospital sales less OTC) and is 2nd largest Filipino pharmaceutical company in the Ethical Segment.


Natrapharm expertise & strengths:

Long experience of partnership with multinational companies

An efficient registration department.

Own distribution.

A strong, well trained and motivated promotional force

Licensors: International companies having licensed products to Natrapharm e.g.

Sanofi-Aventis (Phils.), Abbott (Phils.), Ferrer Laboratorios (Spain), Apotex (Canada), MSD (Phils.), Stada (Germany), Samjin (Korea), Ildong (Korea)

We offer:

The organisation has been built in such a way, that NATRAPHARM has the capacity to market quickly additional products and /lines from new principals.

Products:

They have to fit inside NATRAPHARM/PATRIOT current lines and not to compete internally.

They are not necessarily new products but must be marketed in their country of origin and have an up to date registration dossier.

They can also be products already marketed in the Philippines but which is either very little or no longer promoted by the principal due to other priorities.

NATRAPHARM can either take care of a new line if the products can reach a certain level of growth or NATRAPHARM can host the line. In such case, the responsibility remains with the principal.

In any case , NATRAPHARM is looking for a long term relationship between the principal and NATRAPHARM. NATRAPHARM as 2nd largest Pilipino ethical company is open for co-marketing of innovative products from multinationals.

We are interested in:

Ethical, unique, add-on generic products (also niche products) as well as medical food with indication and clinical trials, metoprolol, clonidine, diltiazem, rosuvastatin, nicardipine inj. with CDT format dossier, climate zone IV stability.

Contact:

Dr. Thomas Högn

International Advisor and Member of the Executive Committee

Natrapharm, Inc., Philippines

Moselstrasse 5

50859 Köln

Germany

Tel.: +49 (0) 172 2910525

e-mail: thomashoegn@gmx.com
Dr Thomas Högn
Natrapharm
LinkedIn logo International Advisor Natrapharm 

Mr Mathias Käsebier Germany

Specialized Pharma M&A Boutique operating since 1991 globally

Mr Mathias Käsebier
Bannert Manlik Consultants GmbH
LinkedIn logo Senior Director 

Ulrich Kinzel Germany

goetzpartners Corporate Finance GmbH
Managing Director 

Dr Ulrich Koch Germany

Bayer AG
VP BD&L Negotiations 

Mr Marc Kuehnelt Germany

-        Looking for in-licensing opportunities of oncological products and

                                            related therapeutic areas such as anti-emetic products etc.

-        Solely sales and marketing of branded oncological generic products

-        only in Germany

Website:
www.onkovis.de
onkovis GmbH
Managing Director 

Cornel Martin Germany

Dr. Willmar Schwabe GmbH & Co KG
Head of Business Development & Licensing 

Dr Jörg Mayer Germany

Dr Jörg Mayer
LTS Lohmann Therapie-Systeme AG
LinkedIn logo Head BD Europe 

Dr Christoph Newzella Germany

Dr. M. Newzella GmbH is an international personnel and business consulting company active within the fields of pharmaceuticals and health care and specializing in the areas of Executive Search, Merger & Acquisition and Product & Licensing.

Thanks to its 35 years of branch experience, Dr. Newzella Consulting has built up an extensive international network of excellent business contacts and has far-reaching knowledge of both companies and markets to supports its clients with individual, flexible and high performance services.


Dr Christoph Newzella
Dr. M. Newzella GmbH
Managing Partner & Director Management Consulting 

Dr Matthias Newzella Germany

Dr. M. Newzella GmbH is an international personnel and business consulting company active within the fields of pharmaceuticals and health care and specializing in the areas of Executive Search, Merger & Acquisition and Product & Licensing.

Thanks to its 35 years of branch experience, Dr. Newzella Consulting has built up an extensive international network of excellent business contacts and has far-reaching knowledge of both companies and markets to supports its clients with individual, flexible and high performance services.


Dr Matthias Newzella
Dr. M. Newzella GmbH
Managing Partner, Director Management Consulting & Head of Executive Search